Sirolimus Eluting ORSIRO Stent Versus Biolimus-eluting NOBORI Stent

A trial with no phase registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 2314 participants.

Also called NCT01879358

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 2,314 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT01879358
Other papers using this trial's data
  • Five-Year Clinical Outcome of the Biodegradable Polymer Ultrathin Strut Sirolimus-Eluting Stent Compared to the Biodegradable Polymer Biolimus-Eluting Stent in Patients Treated With Percutaneous Coronary Intervention: From the SORT OUT VII Trial Circulation. Cardiovascular interventions, 2023-01 DOI, PubMed 36649389
  • Five-year outcomes of patients with diabetes mellitus treated with a sirolimus-eluting or a biolimus-eluting stents with biodegradable polymer. From the SORT OUT VII trial Diabetes & vascular disease research, 2024 DOI, PubMed 39311502, PMC11450620 In the PMC Open Access subset under CC BY-NC.
  • Randomized Comparison of a Biodegradable Polymer Ultrathin Strut Sirolimus-Eluting Stent With a Biodegradable Polymer Biolimus-Eluting Stent in Patients Treated With Percutaneous Coronary Intervention: The SORT OUT VII Trial Circulation. Cardiovascular interventions, 2016-07 DOI, PubMed 27412869

Courtesy of the U.S. National Library of Medicine.

Start date
(registry gives no type) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(anticipated) (from the registry)
Countries
Denmark (from the registry)
Registry status
  • Unknown status (from the registry)

Technical summary

Registry record NCT01879358. Randomized; no masking; primary purpose treatment. Start 2012-11 (registry gives no type); primary completion 2015-02 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Sirolimus Eluting ORSIRO Stent Versus Biolimus-eluting NOBORI Stent
Acronym
SORT OUT VII
Condition
Ischemic Heart Disease
Intervention (Device)
Drug-eluting stent
Lead sponsor
Odense University Hospital (class: other)

Record details

Record id
cardio:ct-nct01879358
Content hash
ff2441a9d623ee4a71281831bb2bd53474157e25e316f347003cafbb68bfac81